Westport · Series C–Late Stage · 7 people tracked
Find your way into HighCape Capital
769 people in our graph share verified history with the HighCape Capital team — schools, employers, funds. One of them is your warm intro.
Investment thesis
HighCape Capital is a growth equity fund focused exclusively on innovative Life Sciences companies, helping them transition from early business stages into thriving organizations. The firm invests across connected health, medical devices and tools, and biotechnology. Its team of experienced operators brings backgrounds in founding, financing, leading, growing, and exiting life sciences companies across multiple industry segments. HighCape adds value by leveraging its operational and scientific experience, working collaboratively with portfolio companies, and supporting entrepreneurship.
Source: firm website, verified Sep 1, 2026.
Team · 7 people
from the firm's website & public directories
Founder mafia
5 people who came through HighCape Capital went on to found or lead other companies.
What they invest in
from 10 of 14 portfolio companiesBiotech ×6Healthtech ×6Medical Devices ×3Deep Tech ×1Digital Health ×1Fintech ×1Hardware ×1Logistics & Supply Chain ×1
HQs:United States×7
Investments · 14 tracked
founders shown can be your intro pathBy year:2024 · 12023 · 12018 · 13 dated
BiotechSilver Spring, US
Michelle LeRoux Williams(Executive Officer)Jeffrey D Hamet(Executive Officer)Lode Debrabandere(Executive Officer, Director)
BoardWilliam Matthew Zuga(Director)Kevin Rakin(Director)Charles Randal Mills(Director)
Develops therapeutics targeting altered NAD metabolism in cancer, based on IP licensed from Yale University.
Develops therapeutics targeting altered NAD metabolism in cancer, using IP licensed from Yale University.
BiotechNew Haven, US
Barbara Fox(Executive Officer, Director)Nicholas J Galli(Executive Officer, Director)Stanley Choy(Executive Officer)inRanjit Bindra(Director)
BoardColleen Cuffaro(Director)inMatthew Cohen(Director)in
Co-investorsCanaan PartnersConnecticut InnovationsOUP (Osage University Partners)
Leader in non-invasive cardiac output and hemodynamic monitoring with its CHEETAH NICOM system; based in Newton, MA with offices in Tel-Aviv and Portland.
HealthtechNewton, US
Christopher Hutchison(Executive Officer, Director)inKevin McArdle(Executive Officer)Yuval Rozen(Executive Officer)
BoardSteven Reeders(Director)Renard Charity(Director)Anthony Moshal(Director)
Co-investorsAscension VenturesMVM Life Science PartnersRobert Bosch Venture Capital
HealthtechNew Haven, US
Ilaa Agarwal(Executive Officer)Stacie Bratcher(Executive Officer)paul reiferson(Executive Officer, Director)ralph finger(Executive Officer, Director)Jennifer Barretta(Executive Officer)Mike Waters(Director)
Co-investorsConnecticut Innovations
Oncology-focused platform company whose alphalex technology enables antigen-independent targeted intracellular delivery of small molecule cancer drugs; based in New Haven, CT.
Cybrexa is a biotechnology company developing cancer therapeutics that use its alphalex peptide-drug conjugate platform to target the low-pH tumor microenvironment for selective delivery.
BiotechHealthtechMedical Devices
Per Hellsund(Co-founder, President & CEO)inRanjit Bindra(Scientific Co-founder & Chief Scientific Advisor)inPeter Glazer(Scientific Co-founder & Chief Medical Advisor)in
Co-investorsConnecticut Innovations
Elutia develops a proprietary drug-eluting biomaterial platform that combines biologic matrices with extended antibiotic release for use in device implantation and soft tissue reconstruction.
BiotechHealthtechMedical Devices
C. Randal Mills(Founder, President & CEO)in
MODIFI provides a digital platform for cross-border trade finance, letting exporters and importers onboard online, receive payment right after shipping, and track trades and supplier payouts in one dashboard.
FintechLogistics & Supply ChainSaaSBainbridge Island, US
Jan Wehrs(Founder)inSven Brauer(Founder)inNelson Holzner(Co-Founder & CEO)inJames Poss(Executive Officer, Director, Promoter)Matthew Otepka(Executive Officer)J. Todd Larson(Executive Officer)
Co-investorsIncubate FundMaersk GrowthNeva Sgr.PICUS CAPITALGlobal Founders CapitalPathway Bioventures
Modifi Bio presents itself as a research-focused biopharmaceutical company developing medicines and vaccines.
BiotechHealthtechNew Haven, US
Ranjit Bindra(Director)Kingson Lin(Cofounder)inKevin L. Rakin(Executive Officer, Director)
BoardLucas de Breed(Director)Kat Kayser-Bricker(Director)
Co-investorsConnecticut InnovationsPathway BioventuresIronwood Capital
Quantum-Si develops next-generation protein sequencing technology that enables single amino acid detection by combining biology, chemistry, artificial intelligence, and semiconductor technology.
BiotechDeep TechHardwareMedical Devices
Jeff Hawkins(CEO)inJeff Keyes(Chief Financial Officer)inChristian LaPointe(General Counsel)inTodd Rearick(Chief Technology Officer)inLindsay Thompson(Chief Human Resources Officer)in
Co-investorsForesite CapitalYuanBio Venture Capital
Offers soft tissue repair solutions combining naturally sourced tissue with polymer; lead product OviTex for hernia repair (NASDAQ: TELA), based in Malvern, PA.
Antony Koblish(Founder)in
Co-investorsOrbiMed
Wellinks provides virtual pulmonary care for patients with respiratory conditions such as COPD, offering at-home remote monitoring, virtual pulmonary rehabilitation, one-on-one clinical coaching, and nurse triage.
Digital HealthHealthtechWellness & FitnessNew Haven, US
Ellen Su(Executive Officer, Director)inLevi DeLuke(Executive Officer, Director)in
Co-investorsConnecticut Innovations
Innovator in non-invasive surgical skin closure devices used in over 100,000 cases across 30+ countries; headquartered in Campbell, CA.
Exits · 1
IPOs and acquisitions across the tracked portfolioAziyo BiologicsNASDAQ: ELUT
Portfolio news
latest coverage across their companiesWellinks · wellinks.com · Aug 18, 2025
Convexity Scientific · wellinks.com · Aug 18, 2025
Frequently asked questions
- How many investments has HighCape Capital made?
- HighCape Capital has 12 tracked investments.
- What stage does HighCape Capital invest at?
- HighCape Capital invests at the Series C, Growth, Late Stage stages.
- What sectors does HighCape Capital focus on?
- HighCape Capital focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is HighCape Capital located?
- HighCape Capital is headquartered in Westport, US.
- Who does HighCape Capital co-invest with?
- HighCape Capital most often shares deals with Connecticut Innovations, Ascension Ventures, Canaan Partners, among 8 tracked co-investors.
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.